| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63a35c66c01451bf66b614d26dc419fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85bb80cdaa3dd890b07ea9157b98b247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36feb582c9440610d37f118ba9663655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f55f09126cf26e6edc4c4eab033800f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bafc627c64252aa2c5b615081c43b41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90d464195c767fd54a73488f51369769 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2011-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01949edf1e4550b0ceda24f74649982f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bb62dfa4154442e630227c01955add6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97d9c13186ea82bcbdf9f5f207b7f083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37169e2ca05251a9095b2ebc19cfeee5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9da46003f28d2dc424accd2806c238e |
| publicationDate |
2012-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012003231-A1 |
| titleOfInvention |
Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid |
| abstract |
The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an amine-containing compound (e.g., an opioid) (including salts thereof) and a pharmaceutically acceptable salt of a non-NSAID cyclic organic acid compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9456985-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2833866-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285101-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9023390-B2 |
| priorityDate |
2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |